Guidelines

In its first update since 2001, the American Cancer Society reaffirms the importance of shared decision making. And although the American Urological Association applauds the new guidance statement on prostate-cancer detection issued by the ACS, the two organizations have divergent opinions regarding when baseline screening should begin.

Start with antisecretory drugs, i.e., proton-pump inhibitors, then make medication, dosage, and lifestyle changes to suit the individual patient.

The revised position statement issued by the North American Menopause Society evaluates the latest evidence and offers recommendations on who should pursue hormone therapy.

Updated guidelines spell out therapy for superficial as well as life-threatening disease variants that are the product of modern medicine.